Back to search

Article

Development and validation a pyroptosis related gene prognostic index for metastatic urothelial carcinoma based on immune checkpoint blockade therapy

2022-05-11

Abstract excerpt

<h4>Background: </h4> Immune checkpoint blockade (ICB) therapy has become a first-line treatment option for metastatic urothelial carcinoma (mUC) patients who do not meet the criteria of cisplatin. Still, only a few people can benefit from it, so useful predictive markers are needed. Methods Download the ICB-based mUC and chemotherapy-based bladder cancer cohorts, and extract the expression data of pyroptosis-rel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
56a6daea-ec3b-5575-af47-129db4da69aa
DOI
10.21203/rs.3.rs-1625353/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and validation a pyroptosis related gene prognostic index for metastatic urothelial carcinoma based on immune checkpoint blockade therapyDOI 10.21203/rs.3.rs-1625353/v1
Select a neighboring publication to make it the new centre.